Search research articles
Contact Us
Filters
Showing results (331-340 of 367) with videos related to
Page
of 37
Sort By:
The Lancet. Oncology
|
April 20, 2013
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yael P Mossé, Megan S Lim, Stephan D Voss, et al.
Pediatric Blood & Cancer
|
July 17, 2020
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group
Jennifer Seelisch, Pedro A De Alarcon, Jamie E Flerlage, et al.
Pediatric Blood & Cancer
|
May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group
Keri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2026
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial
Xin Tie, Changhee Lee, Scott B Perlman, et al.
Cancer
|
September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study
James I Geller, Joseph G Pressey, Malcolm A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group
Suman Malempati, Brenda Weigel, Ashish M Ingle, et al.
Radiology
|
January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)
Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2007
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates
Stephan D Voss, Suzanne V Smith, Nadine DiBartolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)
Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 367) with videos related to
Sort By:
Page
of 37
The Lancet. Oncology
|
April 20, 2013
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yael P Mossé, Megan S Lim, Stephan D Voss, et al.
Pediatric Blood & Cancer
|
July 17, 2020
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group
Jennifer Seelisch, Pedro A De Alarcon, Jamie E Flerlage, et al.
Pediatric Blood & Cancer
|
May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group
Keri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2026
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial
Xin Tie, Changhee Lee, Scott B Perlman, et al.
Cancer
|
September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study
James I Geller, Joseph G Pressey, Malcolm A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group
Suman Malempati, Brenda Weigel, Ashish M Ingle, et al.
Radiology
|
January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)
Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2007
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates
Stephan D Voss, Suzanne V Smith, Nadine DiBartolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)
Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Page
of 37